Searched for
NON SCHEDULED FORMULATIONS
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 27%, according to analystsWe are in a phase in the US-Israel-Iran war where statements are made, then retracted. And, in a matter of just 48 hours, they are made all...- Hexagon Nutrition shares list at 7% premium over IPO price on boursesHexagon Nutrition debuted at a premium of up to 7.2% over its IPO price, in line with grey market expectations. The Rs 138.9 crore issue wa...
- Hexagon Nutrition IPO Day 1: 37% subscription, Grey market signals 27% listing gainHexagon Nutrition's IPO opened strongly on its first day. Retail investors showed significant interest, subscribing 62% of their quota. The...
- Compliance squeeze, global scrutiny redefine India’s $30 billion pharma export playbookAs global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.
- No increase in prices of essential medicines this fiscal year: MandaviyaUnion Minister Mandaviya guarantees no essential medicine price hike due to minimal inflation. NPPA approves slight price increase for 54 m...
- HC quashes NPPA demand notices to Bharat Serums, Bard for allegedly overcharging on drugs, medical devices"Accordingly, and for all the aforesaid reasons, the writ petitions shall stand allowed. The impugned orders dated July 5, 2018, and June 2...
- Exclude cheap drugs from price control: IPASudarshan Jain, secretary general of IPA, in an interview to ET said "We are not against price controls; what we are saying is that the gov...
- Pharma companies seek govt nod to hike medicine pricesThe lobby group asked to allow prices of all scheduled formulations to be increased by 10% with immediate effect. Scheduled drugs are those...
- Cap on trade margin of 42 non-scheduled cancer drugs by NPPA led to up to 90 pc reduction in MRP: Mansukh Mandaviya"The total annual savings on account of revision of ceiling prices of medicines under the National List of Essential Medicines (NLEM), pric...
- Government brings 42 non-scheduled cancer drugs under price controlAs per data available with NPPA, the MRP for 105 brands will be reduced up to 85 per cent entailing minimum saving of Rs 105 crore to consu...
- Prices of 851 essential drug formulations cut in past 2 year: GovernmentIn a written reply to the Lok Sabha, Minister of State for Chemicals and Fertilisers Mansukh L Mandaviya said the government has cut the pr...
- 4 NCR hospitals jacked up prices of branded drugs 12 fold: NPPAThe hospitals have been the “major beneficiaries” of profit in all these cases because they inflated the maximum retail prices of the produ...
- Hospitals prescribe drugs excluded from price control to boost profit: NPPAFour hospitals in the NCR marked up the retail prices of such medicines as much as 12-fold from the rates at which they were purchased, NPP...
- Medical devices notified as drugs must carry printed MRP: NPPAThese devices are non-scheduled formulations and their sales are governed by the provisions of DPCO 2013, the notification said.
- Rs 2,288 cr savings for consumers after NLEM 2015: GovernmentCeiling prices of 464 formulations (amounting to nearly 7,000 different stock keeping units) have been fixed by the government after the an...
- Fixing drug prices helped consumers save Rs 5,000 crore: Government"The total saving to consumers as a result of price control under DPCO 2013 is nearly Rs 4,988 crore," Kumar said.
- Drug price cut yielded Rs 2,772 crore benefit to public: GovernmentAll the NLEM 2011 medicines have been included in the first schedule of DPCO, 2013, and brought under price control.
- NPPA powers not withdrawn, says GovernmentGovt said it has not withdrawn powers delegated to NPPA but only internal guidelines issued by the drug price regulator to cap prices of no...
- Department of Pharmaceuticals examining mechanism for pricing patented drugs: Srikant Kumar JenaThe Department of Pharmaceuticals (DoP) is examining a proposal submitted by a committee to look into the pricing of patented drugs in the ...
- Govt extends new MRP normThe Government has extended the deadline for imported drug formulations by six months to comply with the new labelling norm, which requires...
Load More
